J&J to pay more than $1 billion to settle probe: report (Reuters)

(Reuters) ? Johnson & Johnson is set to pay more than $1 billion to resolve a U.S. civil investigation into the marketing of its Risperdal antipsychotic drug, Bloomberg News reported on Thursday, citing anonymous sources.

The company reached a deal last week with the U.S. attorney in Philadelphia. The deal does not resolve negotiations over a possible criminal plea, the report said.

Johnson & Johnson spokeswoman Teresa Mueller said the company does not comment on rumors or speculation.

In August, J&J said it reached an agreement related to a misdemeanor charge stemming from the Risperdal investigation, although some issues remained unresolved.

(Reporting By Lewis Krauskopf; editing by Andre Grenon)

Source: http://us.rd.yahoo.com/dailynews/rss/diseases/*http%3A//news.yahoo.com/s/nm/20120105/hl_nm/us_johnsonandjohnson

dick clark chris jericho rose bowl school closings quadrantid meteor shower johnny weir osu football